Early onset of neurological symptoms in fragile X premutation carriers exposed to neurotoxins.
about
Fragile X spectrum disordersFragile X-associated tremor/ataxia syndrome.Unstable mutations in the FMR1 gene and the phenotypesDoes diisocyanate exposure result in neurotoxicity?Phenobarbital use and neurological problems in FMR1 premutation carriersUsing mouse models of autism spectrum disorders to study the neurotoxicology of gene-environment interactionsTowards an Understanding of Neuropsychiatric Manifestations in Fragile X Premutation CarriersIncreased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder.Sleep apnea in fragile X premutation carriers with and without FXTAS.Fragile X and autism: Intertwined at the molecular level leading to targeted treatments.Molecular Advances Leading to Treatment Implications for Fragile X Premutation CarriersMouse models of the fragile x premutation and the fragile X associated tremor/ataxia syndrome.Psychosis and catatonia in fragile X: Case report and literature review.Cascade Screening for Fragile X Syndrome/CGG Repeat Expansions in Children Attending Special Education in Sri Lanka.Induced expression of expanded CGG RNA causes mitochondrial dysfunction in vivoTARGETED TREATMENTS IN AUTISM AND FRAGILE X SYNDROMEAdvances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome.Neurocognitive endophenotypes in CGG KI and Fmr1 KO mouse models of Fragile X-Associated disorders: an analysis of the state of the fieldAging in Fragile X Premutation Carriers.Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) Motor Dysfunction Modeled in MiceMolecular Pathophysiology of Fragile X-Associated Tremor/Ataxia Syndrome and Perspectives for Drug Development.Fragile X-associated tremor/ataxia phenotype in a male carrier of unmethylated full mutation in the FMR1 gene.Women who carry a fragile X premutation are biologically older than noncarriers as measured by telomere length.Newborn screening and cascade testing for FMR1 mutations.
P2860
Q26824376-60F6ACFF-80FB-44D3-98D7-9805DFEA0C2CQ26852667-D32F5B2D-5CC7-4C97-AC28-80028C087046Q26996649-C381923F-D9E2-413B-9C45-167551D7A139Q27006543-4351325C-2C30-4E3A-BDBC-68D712BCDE65Q28390629-288F062D-F59C-4073-8417-9CAD8F3EE47FQ28392778-0AF8B55F-A656-4BE3-84EC-F300BA112065Q33863331-A9244755-93F4-4811-9AFA-89E3886A80DBQ33926696-062992D5-E519-4C6B-BD22-A53E8B0738AEQ33943666-A135F63E-2178-41C4-8BEA-A3BE3E07EADDQ34198650-8A96BD96-98A4-4989-A615-C2334CDE0167Q34575595-91800770-09CD-47DB-B413-B89CB9005788Q35037764-6A05A131-7146-4AB1-B1DF-00F5A55E8F0EQ35771116-0173E221-D54A-486A-9CE4-F9CE1B31C3A9Q35875408-4632EC05-A982-4E6A-A3DA-0E1DB3EE9AA0Q36188438-C48F7D7E-8E10-4B0C-B6F6-F5C0AA29223FQ36399716-A0072E65-2C7C-42BC-A925-48078FA5A8EFQ37580522-F0C2389B-F146-4812-8597-F38D8E871242Q37623407-8B20D29B-6CC8-44A1-919E-345CAC30A663Q38849578-F4ABFC62-DF1E-468C-94D3-4F0116BC70F9Q38851924-94A2CE1C-81B7-4402-8341-DFBD654B7521Q38859181-68644946-060F-4E3D-B895-277EAB2C79A9Q50264940-7F443395-103A-4B97-B409-E120185C60DDQ53799975-239F773E-C3E2-46AC-8079-CA5CACD68E9EQ55501801-76AF18EA-B5AB-4B67-91F7-A1F795530603
P2860
Early onset of neurological symptoms in fragile X premutation carriers exposed to neurotoxins.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Early onset of neurological sy ...... rriers exposed to neurotoxins.
@en
Early onset of neurological sy ...... rriers exposed to neurotoxins.
@nl
type
label
Early onset of neurological sy ...... rriers exposed to neurotoxins.
@en
Early onset of neurological sy ...... rriers exposed to neurotoxins.
@nl
prefLabel
Early onset of neurological sy ...... rriers exposed to neurotoxins.
@en
Early onset of neurological sy ...... rriers exposed to neurotoxins.
@nl
P2093
P2860
P1433
P1476
Early onset of neurological sy ...... rriers exposed to neurotoxins.
@en
P2093
Danh V Nguyen
Flora Tassone
Isaac N Pessah
James A Bourgeois
James A Brunberg
Louise Gane
Michele Ono
Patrick E Adams
Paul J Hagerman
Randi Hagerman
P2860
P304
P356
10.1016/J.NEURO.2010.04.002
P577
2010-05-11T00:00:00Z